Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
5.370
USD
-0.370 (-6.45%)
Official Closing Price
Updated: 7:58 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Xeris Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference
January 05, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 243%
January 03, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 31, 2020
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke® in Israel and the Palestinian Authority
December 22, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
Interesting XERS Call Options For February 2021
December 21, 2020
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XERS...
Tags
Stocks
From
Market News Video
72 Biggest Movers From Friday
December 14, 2020
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ...
Tags
NIO
MTEM
IMMP
From
Benzinga
4 Penny Stocks To Watch Before 2021 & 2 Jumped Over 200% In Q4
December 12, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
60 Stocks Moving In Friday's Mid-Day Session
December 11, 2020
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) shares jumped 111.5% to $23.48 on a merger deal with EV charging company ...
Tags
NWG
FAT
TEF
From
Benzinga
Thinking about buying stock in Nantkwest, Ampio Pharmaceuticals, Arbutus Biopharma, Xeris Pharmaceuticals, or iBio Inc?
December 11, 2020
InvestorsObserver issues critical PriceWatch Alerts for NK, AMPE, ABUS, XERS, and IBIO.
From
PR Newswire
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IMMP
IOVA
FATE
From
Benzinga
50 Stocks Moving in Friday's Pre-Market Session
December 11, 2020
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) rose 173.2% to $30.35 in pre-market trading on a merger deal with EV ...
Tags
AQB
BRN
GIK
From
Benzinga
Xeris Pharmaceuticals Receives Positive CHMP Opinion for Ogluo™, Its Ready-To-Use (RTU) Glucagon for Injection, for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Ye
December 11, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and...
From
Business Wire News Releases
41 Stocks Moving in Wednesday's Pre-Market Session
December 02, 2020
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 65.1% to $0.6770 in pre-market trading. Tredegar Corporation (NYSE: TG) rose 35.2% to ...
Tags
MDGS
Top Gainers
FUBO
From
Benzinga
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
November 27, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
First Week of July 2021 Options Trading For Xeris Pharmaceuticals (XERS)
November 23, 2020
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...
Tags
Stocks
From
Market News Video
VTWV's Holdings Could Mean 10% Gain Potential
November 13, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Noteworthy Tuesday Option Activity: XERS, PS, FICO
November 10, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Xeris Pharmaceuticals Inc (XERS), where a total of 10,908 contracts have traded so far,...
Tags
Stocks
From
Market News Video
Xeris Pharmaceuticals: Q3 Earnings Insights
November 09, 2020
Shares of Xeris Pharmaceuticals (NASDAQ:XERS) moved higher by 4.6% in pre-market trading after the company reported Q3 ...
Tags
Market News
XERS
Earnings
From
Benzinga
Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
November 09, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and...
From
Business Wire News Releases
Earnings Scheduled For November 9, 2020
November 09, 2020
Companies Reporting Before The Bell • General Finance (NASDAQ:GFN) is projected to report quarterly earnings at $0.03 ...
Tags
SYNL
URGN
VERI
From
Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
ADPT
VIE
BLUE
From
Benzinga
Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
November 02, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 30, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CRSP
CDAK
IMMU
From
Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
October 21, 2020
Gainers Astrotech Corporation (NASDAQ: ASTC) rose 217.5% to $5.27 in pre-market trading after the company announced partnership ...
Tags
JAGX
SNAP
Premarket Movers
From
Benzinga
16 Stocks Moving In Tuesday's After-Hours Session
October 20, 2020
Gainers Astrotech (NASDAQ: ASTC) shares are trading higher after the company announced it partnered with TheCleveland Clinic ...
Tags
PINS
NFLX
TXN
From
Benzinga
12 Healthcare Stocks Moving In Tuesday's After-Market Session
October 20, 2020
Gainers Xeris Pharmaceuticals (NASDAQ:XERS) stock moved upwards by 10.47% to $5.8 during Tuesday's after-market session. Xeris ...
Tags
PRTA
Health Care
Benzinga
From
Benzinga
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
October 20, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
First Week of XERS December 18th Options Trading
October 16, 2020
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 02, 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.